Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Applying to UH Seidman Cancer Center at Lake Health Mentor Campus · Mentor, Ohio
Answer a few short questions to share with the research team.